The Gross Margin of Hyloris Pharmaceuticals SA (HYL.BR) is 94.74%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 94.74% |
| 2024-12-31 | 97.32% |
| 2023-12-31 | 96.70% |
| 2022-12-31 | 96.81% |
| 2021-12-31 | 96.54% |
| 2020-12-31 | 17.14% |
| 2019-12-31 | 27.47% |
| 2018-12-31 | 28.57% |
| 2017-12-31 | 55.40% |